[1]

Hankey GJ. 2017. Stroke. The Lancet 389:641−654

doi: 10.1016/S0140-6736(16)30962-X
[2]

Hilkens NA, Casolla B, Leung TW, de Leeuw FE. 2024. Stroke. The Lancet 403:2820−2836

doi: 10.1016/S0140-6736(24)00642-1
[3]

Campbell BCV, De Silva DA, Macleod MR, Coutts SB, Schwamm LH, et al. 2019. Ischaemic stroke. Nature Reviews Disease Primers 5:70

doi: 10.1038/s41572-019-0118-8
[4]

Snow SJ. 2016. Stroke and t-PA − triggering new paradigms of care. The New England Journal of Medicine 374:809−811

doi: 10.1056/NEJMp1514696
[5]

Walter K. 2022. What is acute ischemic stroke? JAMA 327:885

doi: 10.1001/jama.2022.1420
[6]

Barthels D, Das H. 2020. Current advances in ischemic stroke research and therapies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:165260

doi: 10.1016/j.bbadis.2018.09.012
[7]

Eltzschig HK, Eckle T. 2011. Ischemia and reperfusion − from mechanism to translation. Nature Medicine 17:1391−1401

doi: 10.1038/nm.2507
[8]

Lyden PD. 2021. Cerebroprotection for acute ischemic stroke: looking ahead. Stroke 52:3033−3044

doi: 10.1161/STROKEAHA.121.032241
[9]

Chamorro Á, Dirnagl U, Urra X, Planas AM. 2016. Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. The Lancet Neurology 15:869−881

doi: 10.1016/S1474-4422(16)00114-9
[10]

Sarkar C, Das B, Rawat VS, Wahlang JB, Nongpiur A, et al. 2023. Artificial intelligence and machine learning technology driven modern drug discovery and development. International Journal of Molecular Sciences 24:2026

doi: 10.3390/ijms24032026
[11]

Gupta R, Srivastava D, Sahu M, Tiwari S, Ambasta RK, et al. 2021. Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Molecular Diversity 25:1315−1360

doi: 10.1007/s11030-021-10217-3
[12]

Li J, Zhou L, Han Z, Wu L, Zhang J, et al. 2024. Impact of halogen bonds on protein-peptide binding and protein structural stability revealed by computational approaches. Journal of Medicinal Chemistry 67:4782−4792

doi: 10.1021/acs.jmedchem.3c02359
[13]

Cheng Y, Shi JQ, Eyre J. 2020. Nonlinear mixed-effects scalar-on-function models and variable selection. Statistics and Computing 30:129−140

doi: 10.1007/s11222-019-09871-3
[14]

Wu Z, Wu Y, Zhu C, Wu X, Zhai S, et al. 2023. Efficient computational framework for target-specific active peptide discovery: a case study on IL-17C targeting cyclic peptides. Journal of Chemical Information and Modeling 63:7655−7668

doi: 10.1021/acs.jcim.3c01385
[15]

Gomes B, Ashley EA. 2023. Artificial intelligence in molecular medicine. New England Journal of Medicine 388:2456−2465

doi: 10.1056/NEJMra2204787
[16]

Mullowney MW, Duncan KR, Elsayed SS, Garg N, van der Hooft JJJ, et al. 2023. Artificial intelligence for natural product drug discovery. Nature Reviews Drug Discovery 22:895−916

doi: 10.1038/s41573-023-00774-7
[17]

Tang B, Paton RS. 2019. Biosynthesis of providencin: understanding photochemical cyclobutane formation with density functional theory. Organic Letters 21:1243−1247

doi: 10.1021/acs.orglett.8b03838
[18]

Subramanian A, Narayan R, Corsello SM, Peck DD, Natoli TE, et al. 2017. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell 171:1437−1452.e17

doi: 10.1016/j.cell.2017.10.049
[19]

Huang J, Fan X, Jin X, Jo S, Zhang HB, et al. 2023. Cannabidiol inhibits Nav channels through two distinct binding sites. Nature Communications 14:3613

doi: 10.1038/s41467-023-39307-6
[20]

Moniruzzaman M, Janjua TI, Martin JH, Begun J, Popat A. 2024. Cannabidiol − help and hype in targeting mucosal diseases. Journal of Controlled Release 365:530−543

doi: 10.1016/j.jconrel.2023.11.010
[21]

Meyer E, Rieder P, Gobbo D, Candido G, Scheller A, et al. 2022. Cannabidiol exerts a neuroprotective and glia-balancing effect in the subacute phase of stroke. International Journal of Molecular Sciences 23:12886

doi: 10.3390/ijms232112886
[22]

Khaksar S, Bigdeli M, Samiee A, Shirazi-Zand Z. 2022. Antioxidant and anti-apoptotic effects of cannabidiol in model of ischemic stroke in rats. Brain Research Bulletin 180:118−130

doi: 10.1016/j.brainresbull.2022.01.001
[23]

Raïch I, Lillo J, Rivas-Santisteban R, Rebassa JB, Capó T, et al. 2024. Potential of CBD acting on cannabinoid receptors CB1 and CB2 in ischemic stroke. International Journal of Molecular Sciences 25:6708

doi: 10.3390/ijms25126708
[24]

Xu BT, Li MF, Chen KC, Li X, Cai NB, et al. 2023. Mitofusin-2 mediates cannabidiol-induced neuroprotection against cerebral ischemia in rats. Acta Pharmacologica Sinica 44:499−512

doi: 10.1038/s41401-022-01004-3
[25]

Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, et al. 2023. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Research 51:D638−D646

doi: 10.1093/nar/gkac1000
[26]

Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, et al. 2018. The MR-Base platform supports systematic causal inference across the human phenome. eLife 7:e34408

doi: 10.7554/eLife.34408
[27]

Satija R, Farrell JA, Gennert D, Schier AF, Regev A. 2015. Spatial reconstruction of single-cell gene expression data. Nature Biotechnology 33:495−502

doi: 10.1038/nbt.3192
[28]

Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, et al. 2019. Fast, sensitive and accurate integration of single-cell data with Harmony. Nature Methods 16:1289−1296

doi: 10.1038/s41592-019-0619-0
[29]

Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. 2019. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nature Biotechnology 37:907−915

doi: 10.1038/s41587-019-0201-4
[30]

Liao Y, Smyth GK, Shi W. 2013. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Research 41:e108

doi: 10.1093/nar/gkt214
[31]

Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, et al. 2015. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research 43:e47

doi: 10.1093/nar/gkv007
[32]

Chen S, Zhou Y, Chen Y, Gu J. 2018. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34:i884−i890

doi: 10.1093/bioinformatics/bty560
[33]

Ramírez F, Dündar F, Diehl S, Grüning BA, Manke T. 2014. deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Research 42:W187−W191

doi: 10.1093/nar/gku365
[34]

Yu G, Wang LG, He QY. 2015. ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31:2382−2383

doi: 10.1093/bioinformatics/btv145
[35]

Bailey TL, Boden M, Buske FA, Frith M, Grant CE, et al. 2009. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Research 37:W202−W208

doi: 10.1093/nar/gkp335
[36]

Li X, Sun Y, Zhou Z, Li J, Liu S, et al. 2024. Deep Learning-driven exploration of pyrroloquinoline quinone neuroprotective activity in Alzheimer's disease. Advanced Science 11:e2308970

doi: 10.1002/advs.202308970
[37]

Zhou L, Du G, Lü K, Wang L, Du J. 2024. A survey and an empirical evaluation of multi-view clustering approaches. ACM Computing Surveys 56:1−38

doi: 10.1145/3645108
[38]

Kearnes S, McCloskey K, Berndl M, Pande V, Riley P. 2016. Molecular graph convolutions: moving beyond fingerprints. Journal of Computer-Aided Molecular Design 30:595−608

doi: 10.1007/s10822-016-9938-8
[39]

Garcia-Bonilla L, Shahanoor Z, Sciortino R, Nazarzoda O, Racchumi G, et al. 2024. Analysis of brain and blood single-cell transcriptomics in acute and subacute phases after experimental stroke. Nature Immunology 25:357−370

doi: 10.1038/s41590-023-01711-x
[40]

Zheng K, Lin L, Jiang W, Chen L, Zhang X, et al. 2022. Single-cell RNA-seq reveals the transcriptional landscape in ischemic stroke. Journal of Cerebral Blood Flow & Metabolism 42:56−73

doi: 10.1177/0271678X211026770
[41]

Ceprián M, Jiménez-Sánchez L, Vargas C, Barata L, Hind W, et al. 2017. Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke. Neuropharmacology 116:151−159

doi: 10.1016/j.neuropharm.2016.12.017
[42]

Lavayen BP, Yang C, Larochelle J, Liu L, Tishko RJ, et al. 2023. Neuroprotection by the cannabidiol aminoquinone VCE-004.8 in experimental ischemic stroke in mice. Neurochemistry International 165:105508

doi: 10.1016/j.neuint.2023.105508
[43]

Rømer Thomsen K, Thylstrup B, Kenyon EA, Lees R, Baandrup L, et al. 2022. Cannabinoids for the treatment of cannabis use disorder: new avenues for reaching and helping youth? Neuroscience & Biobehavioral Reviews 132:169−180

doi: 10.1016/j.neubiorev.2021.11.033
[44]

Rangari VA, O'Brien ES, Powers AS, Slivicki RA, Bertels Z, et al. 2025. A cryptic pocket in CB1 drives peripheral and functional selectivity. Nature 640:265−273

doi: 10.1038/s41586-025-08618-7
[45]

Pacher P, Kunos G. 2013. Modulating the endocannabinoid system in human health and disease − successes and failures. The FEBS Journal 280:1918−1943

doi: 10.1111/febs.12260
[46]

Rubin R. 2018. The path to the first FDA-approved cannabis-derived treatment and what comes next. JAMA 320:1227−1229

doi: 10.1001/jama.2018.11914
[47]

Hybertson BM, Gao B, Bose SK, McCord JM. 2011. Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Molecular Aspects of Medicine 32:234−246

doi: 10.1016/j.mam.2011.10.006
[48]

Dinkova-Kostova AT, Copple IM. 2023. Advances and challenges in therapeutic targeting of NRF2. Trends in Pharmacological Sciences 44:137−149

doi: 10.1016/j.tips.2022.12.003
[49]

Wei Y, Gong J, Xu Z, Thimmulappa RK, Mitchell KL, et al. 2015. Nrf2 in ischemic neurons promotes retinal vascular regeneration through regulation of semaphorin 6A. Proceedings of the National Academy of Sciences of the United States of America 112:E6927−E6936

doi: 10.1073/pnas.1512683112
[50]

Wang L, Qin N, Ge S, Zhao X, Yang Y, et al. 2024. Notoginseng leaf triterpenes promotes angiogenesis by activating the Nrf2 pathway and AMPK/SIRT1-mediated PGC-1/ERα axis in ischemic stroke. Fitoterapia 176:106045

doi: 10.1016/j.fitote.2024.106045
[51]

Amin N, Chen S, Ye S, Wu F, Hussien AB, et al. 2022. Thymoquinone has a synergistic effect with PHD inhibitors to ameliorate ischemic brain damage in mice. Phytomedicine 104:154298

doi: 10.1016/j.phymed.2022.154298
[52]

Huang Y, Li W, Su ZY, Kong AT. 2015. The complexity of the Nrf2 pathway: beyond the antioxidant response. The Journal of Nutritional Biochemistry 26:1401−1413

doi: 10.1016/j.jnutbio.2015.08.001
[53]

He F, Ru X, Wen T. 2020. NRF2, a transcription factor for stress response and beyond. International Journal of Molecular Sciences 21:4777

doi: 10.3390/ijms21134777
[54]

Avsec Ž, Weilert M, Shrikumar A, Krueger S, Alexandari A, et al. 2021. Base-resolution models of transcription-factor binding reveal soft motif syntax. Nature Genetics 53:354−366

doi: 10.1038/s41588-021-00782-6
[55]

Ding P, Wang Y, Zhang X, Gao X, Liu G, et al. 2023. DeepSTF: predicting transcription factor binding sites by interpretable deep neural networks combining sequence and shape. Briefings in Bioinformatics 24:bbad231

doi: 10.1093/bib/bbad231
[56]

Deng L, Wu H, Liu X, Liu H. 2021. DeepD2V: a novel deep learning-based framework for predicting transcription factor binding sites from combined DNA sequence. International Journal of Molecular Sciences 22:5521

doi: 10.3390/ijms22115521
[57]

Ghandi M, Mohammad-Noori M, Ghareghani N, Lee D, Garraway L, et al. 2016. gkmSVM: an R package for gapped-kmer SVM. Bioinformatics 32:2205−2207

doi: 10.1093/bioinformatics/btw203
[58]

Huang S, Zheng C, Xie G, Song Z, Wang P, et al. 2021. FAM19A5/TAFA5, a novel neurokine, plays a crucial role in depressive-like and spatial memory-related behaviors in mice. Molecular Psychiatry 26:2363−2379

doi: 10.1038/s41380-020-0720-x
[59]

Rabinovich-Nikitin I, Kirshenbaum LA. 2023. BMAL1 regulates cell cycle progression and angiogenesis of endothelial cells. Cardiovascular Research 119:1889−1890

doi: 10.1093/cvr/cvad103
[60]

Magalhaes J, Tresse E, Ejlerskov P, Hu E, Liu Y, et al. 2021. PIAS2-mediated blockade of IFN-β signaling: a basis for sporadic parkinson disease dementia. Molecular Psychiatry 26:6083−6099

doi: 10.1038/s41380-021-01207-w
[61]

Zucha D, Abaffy P, Kirdajova D, Jirak D, Kubista M, et al. 2024. Spatiotemporal transcriptomic map of glial cell response in a mouse model of acute brain ischemia. Proceedings of the National Academy of Sciences of the United States of America 121:e2404203121

doi: 10.1073/pnas.2404203121
[62]

Hu C, Li T, Xu Y, Zhang X, Li F, et al. 2023. CellMarker 2.0: an updated database of manually curated cell markers in human/mouse and web tools based on scRNA-seq data. Nucleic Acids Research 51:D870−D876

doi: 10.1093/nar/gkac947
[63]

Jha SK, Nelson VK, Suryadevara PR, Panda SP, Pullaiah CP, et al. 2024. Cannabidiol and neurodegeneration: from molecular mechanisms to clinical benefits. Ageing Research Reviews 100:102386

doi: 10.1016/j.arr.2024.102386
[64]

Atalay Ekiner S, Gęgotek A, Skrzydlewska E. 2022. The molecular activity of cannabidiol in the regulation of Nrf2 system interacting with NF-κB pathway under oxidative stress. Redox Biology 57:102489

doi: 10.1016/j.redox.2022.102489
[65]

Navarrete C, García-Martín A, Correa-Sáez A, Prados ME, Fernández F, et al. 2022. A cannabidiol aminoquinone derivative activates the PP2A/B55α/HIF pathway and shows protective effects in a murine model of traumatic brain injury. Journal of Neuroinflammation 19:177

doi: 10.1186/s12974-022-02540-9
[66]

Joundi RA, Smith EE, Ganesh A, Nogueira RG, McTaggart RA, et al. 2024. Time from hospital arrival until endovascular thrombectomy and patient-reported outcomes in acute ischemic stroke. JAMA Neurology 81:752−761

doi: 10.1001/jamaneurol.2024.1562
[67]

Rojo D, Dal Cengio L, Badner A, Kim S, Sakai N, et al. 2023. BMAL1 loss in oligodendroglia contributes to abnormal myelination and sleep. Neuron 111:3604−3618.e11

doi: 10.1016/j.neuron.2023.08.002
[68]

Liu H, Yang C, Wang X, Yu B, Han Y, et al. 2024. Propofol improves sleep deprivation-induced sleep structural and cognitive deficits via upregulating the BMAL1 expression and suppressing microglial M1 polarization. CNS Neuroscience & Therapeutics 30:e14798

doi: 10.1111/cns.14798
[69]

Shi J, Li W, Ding X, Zhou F, Hao C, et al. 2024. The role of the SIRT1-BMAL1 pathway in regulating oxidative stress in the early development of ischaemic stroke. Scientific Reports 14:1773

doi: 10.1038/s41598-024-52120-5
[70]

Xu L, Liu Y, Cheng Q, Shen Y, Yuan Y, et al. 2021. Bmal1 downregulation worsens critical limb ischemia by promoting inflammation and impairing angiogenesis. Frontiers in Cardiovascular Medicine 8:712903

doi: 10.3389/fcvm.2021.712903
[71]

Qiu P, Jiang J, Liu Z, Cai Y, Huang T, et al. 2019. BMAL1 knockout macaque monkeys display reduced sleep and psychiatric disorders. National Science Review 6:87−100

doi: 10.1093/nsr/nwz002
[72]

Ghosh D, Sehgal K, Sodnar B, Bhosale N, Sarmah D, et al. 2022. Drug repurposing for stroke intervention. Drug Discovery Today 27:1974−1982

doi: 10.1016/j.drudis.2022.03.003
[73]

Cai W, Zhang K, Li P, Zhu L, Xu J, et al. 2017. Dysfunction of the neurovascular unit in ischemic stroke and neurodegenerative diseases: an aging effect. Ageing Research Reviews 34:77−87

doi: 10.1016/j.arr.2016.09.006
[74]

Schaeffer S, Iadecola C. 2021. Revisiting the neurovascular unit. Nature Neuroscience 24:1198−1209

doi: 10.1038/s41593-021-00904-7
[75]

Chen Y, Zhang C, Huang Y, Ma Y, Song Q, et al. 2024. Intranasal drug delivery: the interaction between nanoparticles and the nose-to-brain pathway. Advanced Drug Delivery Reviews 207:115196

doi: 10.1016/j.addr.2024.115196
[76]

Thorne RG, Pronk GJ, Padmanabhan V, Frey WH. 2004. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127:481−496

doi: 10.1016/j.neuroscience.2004.05.029